Analyst at Wolfe Research
Get in Touch
Mentions in the News
4 More Reasons Bausch Health Is A Good Buy
Bausch Health has strong revenue growth ahead with Trulance, its B+L division, and its Salix unit. Siliq exclusion, a minor setback but will ultimately not have
Published: Sep 23 2019
Would you like to be included in the directory? Let us know!
© Street Contxt. All Rights Reserved.